drugset
drugset / Trial / NCT04473651

Safety and Tolerability of Lu AG06479 in Healthy Young Men

NCT04473651 ↗

Phase 1 Terminated 46 enrolled H. Lundbeck A/S
RandomizedSequentialDouble-blindTreatment

Summary

The purpose of this study is to investigate the safety and tolerability of Lu AG06479 and what the body does to Lu AG06479 after swallowing single doses of the drug.

Timeline

Start
2020-07-09
Primary completion
2021-11-10
Completion
2021-11-10

Outcome

Outcome not reported

Stopped (Business): “The study was terminated for strategic reasons.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AG06479 Unknown — Oral

Indications

No indication recorded.